PALISADE BIO, INC.
PALIDrugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 1 past
No catalysts found.
How PALI's past catalysts played out
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
LB1148 | Phase 2 | Ileus | - | - |
Frequently asked questions
What is in PALISADE BIO, INC.'s drug pipeline?→
CatalystAlert tracks 1 drug candidate in PALISADE BIO, INC.'s (PALI) pipeline across Phase 2. Its lead program is LB1148 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is PALISADE BIO, INC.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for PALISADE BIO, INC. (PALI) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track PALI biotech catalysts?→
Add PALI to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow PALISADE BIO, INC.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.